Stockreport

BMO raises Sage Therapeutics price target to $82 [Seeking Alpha]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF BMO Capital Markets maintains its Buy rating on Sage Therapeutics (NASDAQ: SAGE ) and raises the price target to $82 (28% upside) from $68. Shares have rallied almo [Read more]